332 related articles for article (PubMed ID: 23979628)
1. Pathological ventricular remodeling: therapies: part 2 of 2.
Xie M; Burchfield JS; Hill JA
Circulation; 2013 Aug; 128(9):1021-30. PubMed ID: 23979628
[No Abstract] [Full Text] [Related]
2. Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure.
Packer M
JACC Heart Fail; 2019 Oct; 7(10):902-906. PubMed ID: 31521684
[No Abstract] [Full Text] [Related]
3. Waiting Period Before Implantable Cardioverter-Defibrillator Implantation in Newly Diagnosed Heart Failure With Reduced Ejection Fraction: A Window of Opportunity.
DeFilippis EM; Butler J; Vaduganathan M
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29138249
[No Abstract] [Full Text] [Related]
4. [Treatment of chronic systolic heart failure].
Hasenfuse G; Anker SD
Dtsch Med Wochenschr; 2013 Aug; 138(31-32):1556. PubMed ID: 23884736
[No Abstract] [Full Text] [Related]
5. Heart failure medications prescribed at discharge for patients with left ventricular assist devices.
Shreibati JB; Sheng S; Fonarow GC; DeVore AD; Yancy CW; Bhatt DL; Schulte P; Peterson ED; Hernandez A; Heidenreich PA
Am Heart J; 2016 Sep; 179():99-106. PubMed ID: 27595684
[TBL] [Abstract][Full Text] [Related]
6. [Programs for continuing medical education: B session; 1. The pathophysiology of heart failure--is it the disease of the heart?].
Kitakaze M
Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):681-6. PubMed ID: 24796136
[No Abstract] [Full Text] [Related]
7. Myocardial recovery and the failing heart: medical, device and mechanical methods.
Goldfinger JZ; Nair AP
Ann Glob Health; 2014; 80(1):55-60. PubMed ID: 24751565
[TBL] [Abstract][Full Text] [Related]
8. MY APPROACH to treating heart failure with reduced ejection fraction.
Greenberg BH
Trends Cardiovasc Med; 2014 Nov; 24(8):367-8. PubMed ID: 25267506
[No Abstract] [Full Text] [Related]
9. ICDs Are Still an Effective Therapy to Prevent Sudden Cardiac Death in Heart Failure.
DeVore AD; Al-Khatib SM
JACC Heart Fail; 2019 Oct; 7(10):907-910. PubMed ID: 31521688
[No Abstract] [Full Text] [Related]
10. The treatment of chronic heart failure due to left ventricular systolic dysfunction.
Gardner RS; McDonagh TA
Clin Med (Lond); 2004; 4(1):18-22. PubMed ID: 14998261
[No Abstract] [Full Text] [Related]
11. The ABCs of managing systolic heart failure: Past, present, and future.
Okwuosa IS; Princewill O; Nwabueze C; Mathews L; Hsu S; Gilotra NA; Lewsey S; Blumenthal RS; Russell SD
Cleve Clin J Med; 2016 Oct; 83(10):753-765. PubMed ID: 27726827
[TBL] [Abstract][Full Text] [Related]
12. Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.
Samsky MD; Lin L; Greene SJ; Lippmann SJ; Peterson PN; Heidenreich PA; Laskey WK; Yancy CW; Greiner MA; Hardy NC; Kavati A; Park S; Mentz RJ; Fonarow GC; O'Brien EC
JAMA Cardiol; 2020 Mar; 5(3):292-299. PubMed ID: 31734700
[TBL] [Abstract][Full Text] [Related]
13. Neurohormonal and Transcatheter Repair Strategies for Proportionate and Disproportionate Functional Mitral Regurgitation in Heart Failure.
Packer M; Grayburn PA
JACC Heart Fail; 2019 Jun; 7(6):518-521. PubMed ID: 31078484
[No Abstract] [Full Text] [Related]
14. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
Bobbo M; Pinamonti B; Merlo M; Stolfo D; Iorio A; Ramani F; Barbati G; Carriere C; Massa L; Poli S; Scapol S; Gigli M; Di Lenarda A; Sinagra G
Am J Cardiol; 2017 Feb; 119(3):483-489. PubMed ID: 27988039
[TBL] [Abstract][Full Text] [Related]
16. Decade in review--heart failure: 10 Years of progress in HF research--what have we learned?
Krum H
Nat Rev Cardiol; 2014 Nov; 11(11):631-3. PubMed ID: 25178503
[TBL] [Abstract][Full Text] [Related]
17. Outcome of conservative management vs. assist device implantation in patients with advanced refractory heart failure.
Adlbrecht C; Hülsmann M; Wurm R; Eskandary F; Neuhold S; Zuckermann A; Bojic A; Strunk G; Pacher R
Eur J Clin Invest; 2016 Jan; 46(1):34-41. PubMed ID: 26540663
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
[TBL] [Abstract][Full Text] [Related]
19. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis.
Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK
Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
